Riiber Knudsen Trond Reports Share Ownership in OPAY Ltd
Riiber Knudsen Trond files Form 3, detailing share ownership in OPAY Ltd, underscoring the importance of transparency in the banking sector.
Wong Brian Alan-Mingway files Form 3 as OPAY Ltd director
Wong Brian Alan-Mingway files Form 3, revealing his director status at OPAY Ltd, emphasizing transparency and governance in the financial sector.
Aspen Neuroscience's Boerneke Reports Stock Option Grant
Jeffrey Lee Boerneke of Aspen Neuroscience has reported a stock option grant, emphasizing the company's strategy to retain key talent in the competitive pharmaceutical industry.
Kim Vyacheslav Reports Multiple Share Transactions for Kaspi.kz
Kim Vyacheslav disclosed several transactions involving shares of Joint Stock Co Kaspi.kz, reflecting active trading by a significant shareholder.
Matson CEO Matthew J. Cox Reports Stock Sales in SEC Filing
Matthew J. Cox, CEO of Matson, Inc., sold shares on October 29, 2026, as reported in a recent SEC filing, raising questions about future company strategies.
Aspen Neuroscience reports new ownership changes in SEC filing
Aspen Neuroscience reveals new ownership changes, enhancing director Daniel Thomas O's stake in the company, indicating growth in the pharmaceutical sector.
Aspen Neuroscience reports director change in SEC filing
Aspen Neuroscience, Inc. announces a new director, Douglas Carl Fisher, in a recent SEC filing, signaling potential shifts in company strategy.
Aspen Neuroscience CFO Meeter Dalen Files SEC Form 3
Aspen Neuroscience's CFO Meeter Dalen files SEC Form 3, detailing stock options and ownership changes, reflecting transparency in executive operations.
Aspen Neuroscience director discloses stock options in filing
Caryn Peterson of Aspen Neuroscience disclosed stock options in a recent SEC filing, reflecting the company's commitment to leadership and growth.
Morris David Richard Reports Changes in Stock Ownership
Morris David Richard updates stock ownership, affecting family trust holdings and reflecting changes in RBB Bancorp's financial structure.
Aspen Neuroscience reports update on Chief Commercial Officer
Aspen Neuroscience updates on Chief Commercial Officer Lisa Johnson-Pratt, signaling potential shifts in strategy within the pharmaceutical preparations sector.
Cynthia Perettie Files Form 3 as Director of Aspen Neuroscience
Cynthia Dorothy Perettie files Form 3, indicating her director role at Aspen Neuroscience, reflecting governance in the pharmaceutical sector.
Schwab Charles R. sells over 200,000 shares of stock
Charles R. Schwab sold 203,150 shares of Schwab Charles Corp stock, reflecting significant personal transactions by the co-chairman.
Sullivan John James Disposes of 1,200 Shares in Mesa Laboratories
Sullivan John James reports the disposal of 1,200 shares in Mesa Laboratories, reflecting ongoing investment activity and corporate governance transparency.
KeyCorp Officer Andrew J. Paine III Reports Share Transactions
Andrew J. Paine III of KeyCorp disclosed significant share transactions, including a sale of 39,130 shares, impacting investor perceptions in banking.
Carey Albert P acquires shares as Unifi's Executive Chairman
Carey Albert P acquires 43,752 shares in Unifi Inc. as part of a restricted stock unit grant, signaling commitment to long-term leadership.
Boundless Bio's Kevin Tang Buys Over 10,000 Shares of Stock
Kevin Tang of Boundless Bio, Inc. purchases over 10,000 shares, signaling confidence in the pharmaceutical preparations sector amid market fluctuations.
Ramlo Rhonda L. acquires shares in Unifi Inc. as director
Ramlo Rhonda L. acquires 8,948 shares of Unifi Inc. through restricted stock units as part of her role on the Board of Directors.
Unifi CEO Ingle Receives 48,444 Restricted Stock Units Grant
Unifi Inc. CEO Edmund M. Ingle awarded 48,444 restricted stock units, vesting over three years, emphasizing leadership retention in the textile mill industry.
Frazier acquires 1,000 shares of Private Bancorp stock
Andra R. Frazier, EVP and CCO of Private Bancorp of America, Inc., recently acquired 1,000 shares, reflecting confidence in the company.